File Download
  Patent History
  • Application
    CN 20051131580 2005-11-22
  • Publication
    US 20120227120 2012-09-06
  • Granted
    CN 1815234 2006-08-09

granted patent: Synthetic Peptide Targeting Critical Sites On The Sars-Associated Coronavirus Spike Protein Responsible For Viral Infection And Method Of Use Thereof

TitleSynthetic Peptide Targeting Critical Sites On The Sars-Associated Coronavirus Spike Protein Responsible For Viral Infection And Method Of Use Thereof
Granted PatentCN 1815234
Granted Date2006-08-09
Priority Date2004-11-22 US 11/630334P
Inventors
Issue Date2006
Citation
China Patent 1815234. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2006 How to Cite?
AbstractThe Present Invention Provides Methods For Locating Critical Portions Or Sites On The Spike Protein (S Protein) Of Sars-Associated Coronavirus (Sars-Cov) Responsible For The Viral Infection That Causes Severe Acute Respiratory Syndrome (Sars). The Present Invention Also Provides New Synthetic Peptides Targeting Such Critical Portions Or Sites Of The S Protein Of Sars-Cov For Preventing Or Treating Of Sars-Cov Infection In A Subject. The Present Invention Further Provides Methods Of Testing Antiviral Activity Exerted By Antiviral Agents Using Real-Time Quantitative Pcr.
Persistent Identifierhttp://hdl.handle.net/10722/173811

 

DC FieldValueLanguage
dc.date.accessioned2012-11-02T06:19:26Z-
dc.date.available2012-11-02T06:19:26Z-
dc.date.issued2006-
dc.identifier.citationChina Patent 1815234. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2006en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173811-
dc.description.abstractThe Present Invention Provides Methods For Locating Critical Portions Or Sites On The Spike Protein (S Protein) Of Sars-Associated Coronavirus (Sars-Cov) Responsible For The Viral Infection That Causes Severe Acute Respiratory Syndrome (Sars). The Present Invention Also Provides New Synthetic Peptides Targeting Such Critical Portions Or Sites Of The S Protein Of Sars-Cov For Preventing Or Treating Of Sars-Cov Infection In A Subject. The Present Invention Further Provides Methods Of Testing Antiviral Activity Exerted By Antiviral Agents Using Real-Time Quantitative Pcr.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleSynthetic Peptide Targeting Critical Sites On The Sars-Associated Coronavirus Spike Protein Responsible For Viral Infection And Method Of Use Thereofen_HK
dc.typePatenten_US
dc.identifier.emailGuan, Y=yguan@hkucc.hku.hk-
dc.identifier.emailHE, Ming Liang=mlhe@hkucc.hku.hk-
dc.identifier.emailHuang, J=jdhuang@hku.hk-
dc.identifier.emailZheng, B=bzheng@hkucc.hku.hk-
dc.identifier.authorityGuan, Y:rp00397-
dc.identifier.authorityHuang, J:rp00451-
dc.identifier.authorityZheng, B:rp00353-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorGuan, Y-
dc.contributor.inventorHe, Ming Liang-
dc.contributor.inventorHuang, J-
dc.contributor.inventorZheng, B-
patents.identifier.applicationCN 20051131580en_HK
patents.identifier.applicationZL200510131580.9-
patents.identifier.grantedCN 1815234en_HK
patents.description.assigneeUniv Hong Kong [Hk]en_HK
patents.description.countryChina, PRCen_HK
patents.date.publication2012-09-06en_HK
patents.date.granted2006-08-09en_HK
patents.identifier.hkutechidMicro-2004-00170-2en_HK
patents.date.application2005-11-22en_HK
patents.date.priority2004-11-22 US 11/630334Pen_HK
patents.description.ccCNen_HK
patents.identifier.publicationUS 20120227120en_HK
patents.relation.familyCN 1815234 (A) 2006-08-09en_HK
patents.relation.familyUS 2006110758 (A1) 2006-05-25en_HK
patents.relation.familyUS 7491489 (B2) 2009-02-17en_HK
patents.description.kindAen_HK
patents.typePatent_granteden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats